What Is Concentric Remodeling of the Left Ventricle?

Concentric remodeling of the left ventricle is a structural change in which the heart’s main pumping chamber develops thicker walls relative to its internal size, without gaining enough total muscle mass to qualify as full-blown hypertrophy. The walls grow inward rather than outward, shrinking the cavity where blood collects between beats. It sits in a gray zone on the spectrum of cardiac adaptation: the heart is no longer geometrically normal, but it hasn’t crossed the threshold into the kind of enlargement that doctors label left ventricular hypertrophy. That distinction matters because concentric remodeling often develops silently, driven by high blood pressure, obesity, or metabolic problems, and it changes how the heart fills and empties in ways that can quietly erode exercise capacity and raise cardiovascular risk over time.

How Doctors Define and Classify It

Cardiologists sort left ventricular shape into four geometric patterns based on two measurements taken during an echocardiogram or cardiac CT: left ventricular mass (indexed to body size) and relative wall thickness, or RWT. RWT is calculated by doubling the posterior wall thickness and dividing by the internal diameter of the ventricle at the end of its filling phase. A normal heart has both normal mass and an RWT at or below 0.42. Once RWT climbs above that cutoff but mass stays in the normal range, the pattern is called concentric remodeling.1PubMed Central. Relation of Left Ventricular Mass and Concentric Remodeling to Extent of Coronary Artery Disease by Computed Tomography in Patients Without Left Ventricular Hypertrophy The other two categories involve elevated mass: concentric hypertrophy (high mass plus high RWT) and eccentric hypertrophy (high mass with normal or low RWT). These four quadrants form a classification system that has been used since the early 1990s and remains the standard framework for describing how the ventricle reshapes itself under stress.2F1000Research. Prognosis associated with geometric patterns of left ventricular remodeling: systematic review and network meta-analysis

In practical terms, the distinction between concentric remodeling and concentric hypertrophy is a matter of degree. Both involve thicker walls relative to chamber size. In remodeling, the ventricle has compensated by redistributing existing muscle rather than adding bulk. In hypertrophy, the muscle itself has grown heavier. A simple nomogram plotting RWT against indexed mass lets a sonographer quickly place a patient in the correct quadrant.3PubMed. A simple nomogram for determination of echocardiographic left ventricular geometry

Why It Happens

The single most common driver is chronically elevated blood pressure. When the left ventricle has to push blood into arteries that are stiffer or more resistant than normal, it adapts by thickening its walls to reduce the stress on each individual muscle fiber. In a landmark study of patients with essential hypertension, those with concentric remodeling had the highest peripheral vascular resistance of any geometric group. Their left ventricular mass stayed normal not because the pressure load was mild, but because a simultaneous reduction in blood volume returning to the heart (sometimes called “volume underload”) offset the pressure-driven growth signal.4Journal of the American College of Cardiology. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension In other words, the heart is under pressure stress but not volume stress, so the walls thicken without the chamber expanding.

Aortic valve disease can produce a similar picture. In aortic stenosis, a narrowed valve forces the ventricle to generate higher pressures to eject blood, and the resulting remodeling follows a concentric pattern. Imaging research has shown that the specific distribution of wall thickening differs between hypertension and aortic stenosis: hypertension tends to thicken the septum in particular, while stenosis produces a more global increase in wall thickness along with a subtle shift in the left-right axis of the ventricle.5PubMed Central. Differentiating Left Ventricular Remodeling in Aortic Stenosis From Systemic Hypertension Although both conditions push the geometry in a concentric direction, distinguishing the underlying cause matters for treatment. Left ventricular remodeling in aortic stenosis is initially compensatory but eventually becomes maladaptive, leading to worsening diastolic relaxation and overall ventricular performance.6PubMed Central. Left ventricular remodelling patterns in patients with moderate aortic stenosis

Metabolic Syndrome, Obesity, and Insulin Resistance

High blood pressure is not the whole story. A growing body of evidence links concentric remodeling to the cluster of metabolic problems that often travel together: obesity, insulin resistance, high triglycerides, and elevated blood sugar. In the Multi-Ethnic Study of Atherosclerosis (MESA), a large community-based cohort, obesity was independently associated with concentric left ventricular remodeling even after accounting for blood pressure, and ejection fraction remained unchanged.7PubMed Central. The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA) This means the geometric shift can happen before the heart shows any obvious sign of weakened pumping.

A study of elderly men found that insulin resistance tracked closely with relative wall thickness, independent of blood pressure. Men with concentric remodeling had higher fasting insulin, higher glucose levels after an oral glucose challenge, and lower insulin sensitivity compared with men whose ventricles were geometrically normal.8PubMed. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men The implication is that the metabolic environment itself, not just the blood pressure it accompanies, is exerting a remodeling signal on the heart.

Sex Differences in Remodeling

Women and men do not respond to hemodynamic stress in the same way. Among patients with hypertension, women are more likely than men to develop left ventricular remodeling at baseline, and that difference persists over long-term follow-up.9PubMed Central. Sex-Related Differences in Left Ventricular Geometry Patterns in Patients With Arterial Hypertension Part of the explanation may lie in how arterial stiffness affects each sex differently. In women, measures of aortic stiffness and pulsatile hemodynamic load are independently linked to increased relative wall thickness, while the same associations do not hold in men.10PubMed Central. Sex Differences in the Associations of Hemodynamic Load With Left Ventricular Hypertrophy and Concentric Remodeling

Metabolic syndrome compounds these differences. A study comparing men and women with metabolic syndrome found that women with the syndrome had significantly higher wall thickness, greater prevalence of concentric remodeling and hypertrophy, and worse diastolic function compared with women without it. In men, metabolic syndrome did not produce the same significant differences. In statistical modeling, metabolic syndrome independently predicted relative wall thickness and left ventricular mass index in women but not in men.11PubMed. Left ventricular remodeling in patients with metabolic syndrome: influence of gender The takeaway is that women may be more vulnerable to the combination of metabolic and hemodynamic stressors that drives concentric geometry changes.

The Role of Aging and Arterial Stiffness

Even without hypertension, arteries stiffen with age, and that stiffening imposes a growing workload on the left ventricle. Research examining aortic pulse wave velocity, a standard measure of arterial stiffness, found a striking age-dependent pattern. In younger hypertensive patients, stiffness and ventricular geometry were not strongly related. In older patients, however, aortic stiffness correlated significantly with concentric geometry and with reduced ventricular contraction efficiency. The authors concluded that as people age, the link between arterial stiffness and concentric remodeling strengthens, ultimately depressing the ventricle’s pumping function.12PubMed Central. Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension This helps explain why concentric remodeling is increasingly common in older adults, even those whose blood pressure readings are only mildly elevated.

Genetic Influences

Not everyone exposed to the same blood pressure or metabolic conditions develops the same degree of remodeling, and genetics explains part of the variation. Data from the Framingham Heart Study showed that left ventricular geometric pattern clusters within families. Parent-child and sibling pairs were significantly more likely to share the same geometric category than unrelated spouses, and this remained true even after adjusting for age, blood pressure, and body mass index.13PubMed Central. Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study

One specific genetic variant that has been studied in this context involves the ACE gene, which encodes the angiotensin-converting enzyme central to blood pressure regulation. Among hypertensive patients, those carrying the DD variant of the ACE gene had a meaningfully higher left ventricular mass index than those with the II variant, and this difference was unrelated to blood pressure levels.14Cardiovascular Research. Hypertensive left ventricular remodeling and ACE-gene polymorphism Genetics does not determine remodeling on its own, but it does tilt the playing field, making some people more susceptible to wall thickening at any given level of hemodynamic or metabolic stress.

How Concentric Remodeling Affects Heart Function

One of the subtler dangers of concentric remodeling is that the standard measure of heart function, ejection fraction, typically looks fine. The ventricle still squeezes out a normal percentage of the blood inside it. But the chamber has shrunk, so the absolute volume of blood ejected with each beat, the stroke volume, drops. This means the heart has to beat faster or more forcefully to deliver the same amount of blood to the body during exercise.15PubMed Central. Left ventricular concentric remodeling and impaired cardiorespiratory fitness in patients with heart failure and preserved ejection fraction Patients often notice this as reduced exercise tolerance before any formal test picks up a problem.

More advanced imaging techniques, such as speckle-tracking echocardiography, reveal that the heart’s deformation in the long axis (top-to-bottom shortening) is already reduced in concentric remodeling, even when ejection fraction is preserved. The ventricle compensates by increasing circumferential shortening (squeezing around its diameter), which masks the overall loss on routine testing.16PubMed Central. Ventricular Remodeling in Heart Failure with Preserved Ejection Fraction This is why many experts consider concentric remodeling an early stage on the road to heart failure with preserved ejection fraction, a condition in which the heart fills poorly despite pumping with seemingly normal strength.

In women with chest pain but no significant coronary blockages, concentric remodeling was associated with measurably impaired heart muscle deformation and worse early diastolic relaxation, even though ejection fraction and total heart mass were similar to those in women with normal geometry.17European Heart Journal – Cardiovascular Imaging. Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve Findings like these underscore that a normal ejection fraction does not mean a normal heart.

Does Concentric Remodeling Increase the Risk of Heart Attack or Death?

This is where the evidence gets a bit complicated. A meta-analysis pooling data from multiple studies found that people with concentric remodeling had a roughly 36 percent higher adjusted risk of cardiovascular events compared with those with normal geometry, a statistically significant increase. The elevated risk was most clearly seen in hypertensive patients and in studies that tracked both fatal and nonfatal events.18Journal of Human Hypertension. Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis

On the other hand, a study specifically looking at patients with stable coronary artery disease (the Heart and Soul Study) found that after adjusting for other risk factors, concentric remodeling was not independently associated with death or heart failure hospitalization over about five years. Concentric and eccentric hypertrophy were, but remodeling alone was not.19PubMed. Relation of concentric remodeling to adverse outcomes in patients with stable coronary artery disease (from the Heart and Soul Study) One reasonable way to reconcile these findings is that concentric remodeling raises risk in populations where it reflects ongoing, poorly controlled hemodynamic or metabolic stress (especially untreated or undertreated hypertension), but carries less independent danger once blood pressure and coronary disease are well managed. Either way, it is considered a marker that something is putting abnormal load on the heart, and ignoring it is generally a bad idea.

Distinguishing Pathological Remodeling from Athletic Adaptation

Exercise also reshapes the heart, and this sometimes causes confusion. Endurance athletes (runners, cyclists, swimmers) tend to develop eccentric hypertrophy, in which the chamber enlarges and the walls thicken proportionally. Strength-trained athletes (weightlifters, throwers) tend toward concentric hypertrophy, where higher peak pressures during heavy lifting drive wall thickening. In both cases the remodeling is considered physiological: the heart adapts, function stays normal or improves, and the changes reverse with detraining.20Journal of Sports Medicine and Therapy. Physiological Versus Pathological Cardiac Adaptations in Athletes: Unravelling the Complexities of the Athlete’s Heart through Advanced Echocardiographic Imaging

The key difference between the athlete’s heart and pathological remodeling lies in what is happening at the cellular level. Physiological hypertrophy preserves normal muscle-cell organization and function, whereas pathological remodeling involves fibrosis (scar-like tissue replacing normal muscle), abnormal cell signaling, and eventually stiffening of the ventricle wall.21PubMed. The athlete’s heart vs. the failing heart: can signaling explain the two distinct outcomes? In clinical practice, the distinction is usually clear from context, but in borderline cases, advanced imaging or exercise testing can help separate the two.

Can Concentric Remodeling Be Reversed?

Yes, and blood pressure treatment is the most established route. In a trial nested within the PREVER-Treatment study, 60 percent of participants with stage I hypertension had concentric remodeling at baseline. After 18 months of antihypertensive treatment, relative wall thickness dropped significantly, left ventricular mass index decreased, and the proportion of participants with normal geometry rose from about 31 percent to 49 percent.22American Journal of Hypertension. Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Antihypertensive Treatment in Stage I Hypertension The improvement occurred even in patients with relatively mild hypertension, suggesting that early treatment matters.

Among drug classes, medications that block the renin-angiotensin system, particularly ACE inhibitors and angiotensin receptor blockers (ARBs), have the strongest track record for reversing concentric geometry. In the large LIFE trial, the ARB losartan produced greater regression of left ventricular mass index than the beta-blocker atenolol, and the difference was driven mainly by reduced concentricity of the ventricle.23PubMed. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial Add-on therapy can further improve regression, though the best combination beyond an ACE inhibitor or ARB is still debated.24PubMed Central. Regression of the Left Ventricular Hypertrophy in Patients with Essential Hypertension on Standard Drug Therapy

A newer class of drugs, SGLT2 inhibitors (originally developed for type 2 diabetes), has shown promise in reversing left ventricular remodeling more broadly. Meta-analyses of randomized trials found that SGLT2 inhibitors significantly reduced left ventricular mass index and ventricular volumes compared with placebo.25PubMed Central. Effect of sodium-glucose cotransporter protein-2 inhibitors on left ventricular hypertrophy in patients with type 2 diabetes: A systematic review and meta-analysis The benefits appear to extend across heart failure types, with reduction in ventricular volumes tending to be greater in patients with reduced ejection fraction and mass regression more evident in those with preserved ejection fraction.26PubMed Central. Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies

Lifestyle Changes and Reverse Remodeling

Medication isn’t the only lever. In an animal model designed to mimic the features of heart failure with preserved ejection fraction, researchers demonstrated that stopping the hypertensive stimulus, introducing voluntary exercise, and switching to a low-fat diet reversed both left ventricular hypertrophy and concentric remodeling within four weeks.27PubMed. Cardiac reverse remodeling in a mouse model with many phenotypical features of heart failure with preserved ejection fraction: effects of modifying lifestyle Human case reports echo this finding: significant weight loss achieved through dietary changes and regular physical activity has been accompanied by measurable decreases in ventricular dimensions and improvements in ejection fraction.28PubMed. Weight reduction via life-style modifications results in reverse remodelling and cardiac functional improvement in a patient with obesity Large-scale human trials specifically testing lifestyle-driven reversal of concentric remodeling are limited, but the direction of the evidence is encouraging, especially for patients whose remodeling is driven by obesity and metabolic dysfunction rather than fixed structural valve disease.

Imaging Pitfalls Worth Knowing About

Because the diagnosis of concentric remodeling depends entirely on measurements of wall thickness and chamber size, the accuracy of those measurements matters enormously. Echocardiography is the workhorse tool, but it is operator-dependent and can be limited by body habitus, especially in obese patients. Cardiac MRI is generally considered the gold standard for measuring ventricular dimensions, and comparisons between the two methods reveal that echocardiography tends to overestimate wall thickness, with the largest discrepancies showing up in patients with moderate to severe hypertrophy.29PubMed. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography For someone sitting right at the RWT cutoff of 0.42, this measurement variability could mean the difference between being classified as normal geometry or concentric remodeling. If a borderline result on echocardiography is driving clinical decisions, cardiac MRI can help clarify the picture.

Fibrosis, the scarring that develops as remodeling becomes more advanced, is another feature that cardiac MRI can detect but standard echocardiography cannot. The progressive buildup of fibrotic tissue in the heart wall increases passive stiffness, worsens diastolic function, and represents a transition point toward a more serious condition.30Oxford Academic (European Heart Journal). Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment Identifying fibrosis early can help guide decisions about how aggressively to treat and how closely to monitor.